Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olesya Chayka

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular and Cellular Biology|December 17, 2004
v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoterOlesya Chayka, Jörg Kintscher, Daniel Braas, et al.
The Journal of Biological Chemistry|October 21, 2009
Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-mybCarola Wilczek, Olesya Chayka, Annette Plachetka, et al.
The Journal of Biological Chemistry|December 6, 2014
Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cellsOlesya Chayka, Cosimo Walter D'Acunto, Odette Middleton, et al.
Molecular and Cellular Biology|January 16, 2008
C/EBPbeta induces chromatin opening at a cell-type-specific enhancerAnnette Plachetka, Olesya Chayka, Carola Wilczek, et al.
Blood Cells, Molecules & Diseases|October 24, 2007
A dual activation mechanism for Myb-responsive genes in myelomonocytic cellsVichanan Yamkamon, Olga Ivanova, Daniel Braas, et al.
Advances in Cancer Research|November 3, 2009
Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesisArturo Sala, Saverio Bettuzzi, Sabina Pucci, et al.
Oncotarget|January 18, 2012
Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasSandra Cantilena, Fabio Pastorino, Annalisa Pezzolo, et al.
Oncotarget|February 10, 2011
Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loopFrancesco Gualdrini, Daisy Corvetta, Sandra Cantilena, et al.
The Journal of Biological Chemistry|January 31, 2013
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implicationsDaisy Corvetta, Olesya Chayka, Samuele Gherardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2013
Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cellsGiorgia Santilli, Izabela Piotrowska, Sandra Cantilena, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular and Cellular Biology|December 17, 2004
v-Myb mediates cooperation of a cell-specific enhancer with the mim-1 promoterOlesya Chayka, Jörg Kintscher, Daniel Braas, et al.
The Journal of Biological Chemistry|October 21, 2009
Myb-induced chromatin remodeling at a dual enhancer/promoter element involves non-coding rna transcription and is disrupted by oncogenic mutations of v-mybCarola Wilczek, Olesya Chayka, Annette Plachetka, et al.
The Journal of Biological Chemistry|December 6, 2014
Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cellsOlesya Chayka, Cosimo Walter D'Acunto, Odette Middleton, et al.
Molecular and Cellular Biology|January 16, 2008
C/EBPbeta induces chromatin opening at a cell-type-specific enhancerAnnette Plachetka, Olesya Chayka, Carola Wilczek, et al.
Blood Cells, Molecules & Diseases|October 24, 2007
A dual activation mechanism for Myb-responsive genes in myelomonocytic cellsVichanan Yamkamon, Olga Ivanova, Daniel Braas, et al.
Advances in Cancer Research|November 3, 2009
Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesisArturo Sala, Saverio Bettuzzi, Sabina Pucci, et al.
Oncotarget|January 18, 2012
Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasSandra Cantilena, Fabio Pastorino, Annalisa Pezzolo, et al.
Oncotarget|February 10, 2011
Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loopFrancesco Gualdrini, Daisy Corvetta, Sandra Cantilena, et al.
The Journal of Biological Chemistry|January 31, 2013
Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: functional and therapeutic implicationsDaisy Corvetta, Olesya Chayka, Samuele Gherardi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2013
Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cellsGiorgia Santilli, Izabela Piotrowska, Sandra Cantilena, et al.
Pageof 2